Coordinated heart care for chronic coronary disease
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether coordinating care between your regular doctor and heart specialists helps manage chronic coronary disease. It focuses on people with high cholesterol despite taking strong statin medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with chronic coronary disease (a long-term heart condition).
- You also have diabetes, familial high cholesterol, recurrent coronary disease, or chronic kidney disease.
- You are currently taking a high-dose statin (like atorvastatin 80 mg or rosuvastatin 20/40 mg) or a lower dose if you couldn't tolerate the higher ones.
- A recent blood test (within the last 6 months) shows your LDL (bad) cholesterol is above 100 mg/dl while on your current medication.
- You are not taking PCSK9 inhibitors (another type of cholesterol-lowering injection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an extra medication (inclisiran) added to your usual cholesterol-lowering treatment, compared to usual treatment alone, to see if it further lowers 'bad' cholesterol after a recent heart attack.
This study tests whether giving a new cholesterol-lowering drug, inclisiran, early during a hospital stay after a heart attack can help lower bad cholesterol (LDL) more effectively than usual care. It may reduce the risk of future heart problems.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
This study tests two newer cholesterol-lowering medications (inclisiran and alirocumab) together in people who've had heart problems or strokes and cannot tolerate standard cholesterol drugs. The goal is to see if this combination safely lowers cholesterol further and reduces future cardiovascular events.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
Hear when a new Ischemic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.